Advertisement

111, Inc. YI

Set alert

Price alert · YI

All alert types
2.85 USD -0.15 -5.00%

At close · Oct 30

2.92 +0.07 +2.46%

After hours · Oct 30, 4:00 PM ET

Bid
2.75 × 2
Ask
3.04 × 2
2.85 Day range 2.94
2.56 52-week range 8.38
YTD
+11.33%
1 year
-35.08%
Open
2.94
Prev close
3.00
Mkt cap
25.07M
Vol
21.64K
Avg vol
13.88K
EPS
10.26
P/E
0.28
Div yield
0.00%
More statistics
Low
2.85
High
2.94
Forward P/E
5.29
Beta
0.39
Short ratio
0.25
Inst. own
23.89%
Dividend
0.00
Ex-div date
50-d avg
0.7526
200-d avg
0.9771
1y target
0.00

5Y chart

Chart tools
Interval

Events in this range
  • Aug 24, 2023Earnings: -0.1; estimate 0; surprise —%
  • Nov 30, 2023Earnings: -0.16; estimate 0; surprise —%
  • Mar 21, 2024Earnings: -0.34; estimate 0; surprise —%
  • May 23, 2024Earnings: -0.02; estimate 0; surprise —%
  • Aug 29, 2024Earnings: -0.02; estimate 0; surprise —%
  • Nov 27, 2024Earnings: -0.02; estimate 0; surprise —%
  • Jan 24, 2025Split: 1 for 10
Signals (73)
NameDateAgo
RSI: OversoldOct 30, 20261 day ago
RSI: OversoldOct 5, 20263 weeks ago
SMA: BearishMay 25, 20265 months ago
MACD: Sell SignalApr 27, 20266 months ago
SMA: BearishMar 9, 20267 months ago
SMA: BullishJan 12, 20269 months ago
SMA: BullishJan 12, 20269 months ago
MACD: Buy SignalJan 12, 20269 months ago
RSI: OversoldDec 22, 202510 months ago
RSI: OversoldDec 8, 202510 months ago
RSI: OversoldNov 17, 202511 months ago
SMA: BearishJul 28, 20251 year ago
SMA: BearishJun 16, 20251 year ago
SMA: BullishMay 26, 20251 year ago
MACD: Sell SignalApr 21, 20251 year ago
SMA: BearishMar 31, 20251 year ago
SMA: BullishJan 20, 20251 year ago
SMA: BullishJan 20, 20251 year ago
MACD: Buy SignalJan 20, 20251 year ago
RSI: OverboughtJan 20, 20251 year ago
MACD: Sell SignalJan 13, 20251 year ago
SMA: BearishDec 23, 20241 year ago
SMA: BullishNov 25, 20241 year ago
MACD: Buy SignalNov 25, 20241 year ago
MACD: Sell SignalNov 18, 20241 year ago
SMA: BearishOct 14, 20242 years ago
SMA: BullishSep 30, 20242 years ago
MACD: Buy SignalSep 30, 20242 years ago
RSI: OversoldSep 9, 20242 years ago
MACD: Sell SignalSep 2, 20242 years ago
SMA: BearishAug 5, 20242 years ago
SMA: BullishJul 22, 20242 years ago
SMA: BearishJul 15, 20242 years ago
SMA: BullishJul 8, 20242 years ago
SMA: BearishJun 3, 20242 years ago
SMA: BullishMay 13, 20242 years ago
MACD: Buy SignalApr 22, 20242 years ago
MACD: Sell SignalApr 15, 20242 years ago
SMA: BearishMar 18, 20242 years ago
RSI: OversoldMar 18, 20242 years ago
SMA: BullishMar 11, 20242 years ago
MACD: Buy SignalMar 4, 20242 years ago
RSI: OversoldJan 29, 20242 years ago
RSI: OversoldJan 15, 20242 years ago
RSI: OversoldDec 4, 20232 years ago
MACD: Sell SignalAug 28, 20233 years ago
SMA: BearishAug 21, 20233 years ago
SMA: BearishAug 21, 20233 years ago
SMA: BullishJul 10, 20233 years ago
SMA: BullishJul 10, 20233 years ago
MACD: Buy SignalJul 10, 20233 years ago
SMA: BearishJun 19, 20233 years ago
MACD: Sell SignalJun 19, 20233 years ago
MACD: Buy SignalJun 12, 20233 years ago
SMA: BullishMay 29, 20233 years ago
SMA: BearishMay 22, 20233 years ago
SMA: BullishApr 24, 20233 years ago
SMA: BearishMar 6, 20233 years ago
SMA: BullishFeb 27, 20233 years ago
SMA: BearishFeb 20, 20233 years ago
MACD: Sell SignalJan 30, 20233 years ago
SMA: BearishJan 16, 20233 years ago
SMA: BullishNov 7, 20223 years ago
SMA: BearishSep 26, 20224 years ago
SMA: BearishAug 1, 20224 years ago
SMA: BullishJul 18, 20224 years ago
SMA: BullishJun 20, 20224 years ago
RSI: OversoldMay 16, 20224 years ago
SMA: BearishMar 28, 20224 years ago
SMA: BullishMar 14, 20224 years ago
SMA: BearishFeb 14, 20224 years ago
RSI: OversoldFeb 14, 20224 years ago
SMA: BullishFeb 7, 20224 years ago

Key statistics

Market cap
63.40M
Enterprise value
618.31M
Trailing P/E
0.00
Forward P/E
5.29
PEG ratio
0.00
Price / sales
0.00
Price / book
0.00
EPS (TTM)
-0.41
Beta
0.39
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-2.25%
Revenue (TTM)
14.73B
Revenue growth
-1.50%
Free cash flow
359.45M
Total cash
595.45M
Total debt
245.54M
Return on equity
-66.14%
Shares outstanding
49.66M
Short % of float
0.07%
50-day average
0.7526
200-day average
0.9771

Analyst view

Consensus: none

Price target (mean) 0.00

Next earnings

Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
YI Revenue — quarterly 2.30B
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
YI Net income — quarterly -39.13M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

YI recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 27, 2024Sep 1, 20240.00-0.02——
Aug 29, 2024Jun 1, 20240.00-0.02——
May 23, 2024Mar 1, 20240.00-0.02——
Mar 21, 2024Dec 1, 20230.00-0.34——
Nov 30, 2023Sep 1, 20230.00-0.16——
Aug 24, 2023Jun 1, 20230.00-0.10——

About 111, Inc.

111, Inc., together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates in two segments, B2C and B2B. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services that include online consultation services and electronic prescription services to consumers. It offers prescription and over-the counter drugs, including western and traditional Chinese medicines; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices comprising bandages and thermometers; and personal care products consisting of skin care, birth control, sexual wellness products, and baby products. The company also operates an online marketplace where third-party sellers can directly sell to pharmacies; provides online loan application services to the clients of 1 Pharmacy, which include pharmacies and wholesalers; and data and supply chain integration services. In addition, it offers warehousing, logistics, procurement, research and development, and consulting services; and software development and information technology support services. The company operates offline retail pharmacies under the Yi Hao Pharmacy brand name in Guangdong, Guangzhou, Tianjin, and Kunshan. It serves pharmacies, pharmaceutical companies, medical professionals, and insurance companies. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the People's Republic of China.

Sector
Healthcare
Industry
Medical Distribution
Country
China

News

Your note

Sign in to keep a note on YI — it syncs with the Stock Master app.

Institution ownership

YI institution ownership
Holder% heldSharesValueReported
Renaissance Technologies, LLC0.27%134,24799.36KSep 29, 2024
Morgan Stanley0.10%51,66838.24KSep 29, 2024
Citadel Advisors Llc0.08%41,92731.03KSep 29, 2024
Geode Capital Management, LLC0.07%33,10024.50KSep 29, 2024
Xtx Topco Ltd0.06%31,12323.03KSep 29, 2024
HRT Financial LP0.03%15,02811.12KSep 29, 2024

Fund ownership

YI fund ownership
Holder% heldSharesValueReported
Fidelity NASDAQ Composite Index Fund0.07%33,10024.50KOct 30, 2024
Advertisement